Logo of nihpaLink to Publisher's site
PMC full text:
Methods. Author manuscript; available in PMC 2010 Nov 1.
Published in final edited form as:
Methods. 2009 Nov; 49(3): 219–226.
Published online 2009 May 4. doi: 10.1016/j.ymeth.2009.04.012

Table 2

Cell lines successfully used in the retrotransposition assay

Cell Line (organism)DescriptionReference
143B TK-(human)Osteosarcoma[56]
293T (human)Embryonic kidney with large T antigen[36]
CC-2509 (human)Primary fibroblasts[36]
CC-2591 (human)Primary hepatocytes[36]
CHO-UV20 (hamster)Defective in DNA repair (ERCC1-)[54]
CRL-12203 (chicken)Embryonic fibroblasts[101]
DLD-1 (human)P53 defective[51]
Gli36 (human)Glioma[36]
H1, H7, H9, BG01,HSF-6, Cyth25 (human)Human embryonic stem cells[102]
H460 (human)Lung adenocarcinoma[103]
HCT116 (human)Colon cancer[31]
HEK293 (human)Embryonic kidney[44]
Hep3B (human)Hepatocellular carcinoma[36]
HT1080 (human)Fibrosarcoma, both p53 wild-type and defective[51]
IMR-90 (human)Primary fibroblasts, only work when dividing[104]
LTK- (mouse)L cells lacking thymidine kinase[7]
MCF-7 (human)Breast adenocarcinoma[51]
MCF-7-bcl2 (human)Apoptosis suppressed[101]
NIH3T3 (mouse)Fibroblasts, transient assay[78]
RCL (rat)Chloroleukemia[90]
SW480 (human)p53 defective[51]
T47D (human)Carcinoma[52]
V3, XR-1 CHO (hamster)Defective in telomeres and non-homologous end joining or DNA repair[29]
YZ-5 (human)Competent for altered telomere maintenance[53]
-